(Total Views: 317)
Posted On: 02/07/2020 1:02:23 PM
Post# of 8398
WOW!! What A Statement By The FDA!!
"The results indicate that ActiPatch significantly reduced pain (measured by VAS pain) associated with COA in the device treatment group, and that the treatment differences between device-treatment and NSAID-treatment groups was significant (p<0.05)."
Psssst!!
Big Pharma!!
Paying Attention!!
The Beast Is Off The Leash!!
Monster!!
"The results indicate that ActiPatch significantly reduced pain (measured by VAS pain) associated with COA in the device treatment group, and that the treatment differences between device-treatment and NSAID-treatment groups was significant (p<0.05)."
Psssst!!
Big Pharma!!
Paying Attention!!
The Beast Is Off The Leash!!
Monster!!
(0)
(0)
